Concepedia

Annpey Pong

AP

Statistics

Publications

27

Citations

979

H-Index

16

Active since

1982

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

University of Toronto

Harvard University

University of Tennessee Health Science Center

Annpey Pong is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1982–2022

27

Publications

27

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial

David Z.I. Cherney, B Charbonnel, Francesco Cosentino et al. · Diabetologia · 2021 · 163 citations · Full text

Medicine, Nephrology, Pharmacotherapy +12

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

Kelly Parsey, Annpey Pong · Contraception · 2000 · 149 citations

Medicine, Gynecology, Pharmacology +16

Statistical Consideration of Adaptive Methods in Clinical Development

Shein‐Chung Chow, Mark Chang, Annpey Pong · Journal of Biopharmaceutical Statistics · 2005 · 134 citations

Public Health, Biostatistics, Clinical Data Management +10

Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies

Philip Lister, Annpey Pong, Stephen A. Chartrand et al. · Antimicrobial Agents and Chemotherapy · 1997 · 46 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Ertugliflozin and Slope of Chronic eGFR

David Z.I. Cherney, Francesco Cosentino, Samuel Dagogo‐Jack et al. · Clinical Journal of the American Society of Nephrology · 2021 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 27